AcuFocus

AcuFocus Inc. is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of near vision. The Company's proven, proprietary technology platform uses a small aperture - or pinhole - effect to allow focused light rays to reach the retina and bring objects into focus. The result is unique, reliable and long-term. Using this small aperture concept, two products have been developed: the Company's flagship product, the KAMRA™ corneal inlay, and the innovative IC-8™ IOL. The KAMRA inlay helps presbyopic patients restore their near vision while maintaining their distance vision. The IC-8 IOL* provides a range of vision across various distances, from near to far, and is specifically designed for patients with cataracts. In addition to these products, AcuFocus also distributes the AcuTarget HD™ diagnostic and surgical planning instrument. This instrument is essential for the optimal treatment and technology selection for a broad range of patients, including LASIK, cataract, dry eye and presbyopes.
Type
Private
HQ
Irvine, US
Founded
2001
Employees
75 (est)+3%
AcuFocus was founded in 2001 and is headquartered in Irvine, US

Key People at AcuFocus

Nick Tarantino

Nick Tarantino

Chief Global Clinical and Regulatory Officer
Charles E. Larsen

Charles E. Larsen

Co-Founder
Jason Tester

Jason Tester

CFO
Dan Siems

Dan Siems

COO

AcuFocus Locations

Irvine, US

AcuFocus Metrics

AcuFocus Summary

Founding Date

2001

Total Funding

$178 M

Latest funding size

$66 M

Time since last funding

3 months

Investors

AcuFocus's latest funding round of $66 M was in September 2016. In total, AcuFocus has raised $178 M.

AcuFocus Company Life